The Longevity Science Foundation (LSF) reports that the use of psychedelics for mental health treatments is gaining momentum at an unprecedented pace. Compounds such as MDMA, ketamine, and psilocybin have demonstrated encouraging outcomes in treating PTSD, depression, and addiction. In addition, researchers have shown that ketamine and psilocybin may assist in regenerating neural connections, which could have far-reaching implications in the development of treatments for neurodegenerative disorders associated with aging, as per the LSF.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…